Pulished Date October, 2018
ID: 536
Share on
Share on

Latin America Preclinical In-vivo Imaging Market By Modality (optical Imaging, Nuclear Imaging, Micro-MRI, Micro-CT, Micro-ultrasound, Photoacoustic, And Magnetic Particle Imaging Systems), By Reagent (optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents, And CT Contrast Agents), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Pulished: October, 2018
ID: 536
Pages: 133

Overview of the Market:
Latin America Preclinical in-vivo imaging market
has been estimated at USD 32.1 Million in 2018 and is projected to reach USD  42.96 Million by 2023, at a CAGR of 6.00% during the forecast period from 2016 to 2022. Preclinical imaging systems are imaging systems that look deep into the tissues of living subjects. In-vivo imaging requires a simultaneous combination of imaging modalities to examine dynamic characteristics of cells and tissues.

In Latin America, increased outsourcing of preclinical research activities to Latin America based CROs by big pharmaceutical and biotechnological companies, owing to low cost of research in these nations is driving the market growth. However, high cost and data requirements for bringing new imaging technology is the key reason hampering the growth of preclinical imaging market in this region.

Latin America market for Preclinical In-vivo Imaging is segmented based on Modality and Reagents. Based on modality, the Latin America preclinical imaging market is divided into seven major segments, namely, optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems. The preclinical optical imaging systems market includes bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems, optical + X-ray/optical + CT imaging systems. The preclinical nuclear imaging systems market comprises micro-PET systems (standalone PET, PET/CT, and PET/MRI), micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI), and tri-modality (PET/SPECT/CT) imaging systems. Bases on the reagents, the Latin America preclinical imaging market is divided into five segments, namely, optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. The optical imaging reagents market is further sub-segmented as bioluminescent and fluorescent imaging reagents. Likewise, the nuclear imaging reagents market is divided as preclinical PET tracers and SPECT probes.

Geographical Analysis: 
Geographically, Latin America market for Preclinical In-vivo Imaging is segmented into Brazil, Argentina and Mexico. Rising adoption of multi-modality imaging systems in preclinical research studies and growing number of CROs in emerging markets like Brazil, are attracting the companies to invest in Latin American region.

key players in the market:
Aspect Imaging, Biospace Lab S.A., Bruker Corporation, LI-COR Biosciences, Mediso Ltd., MILabs B.V., MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging, and FUJIFILM VisualSonics, Inc. are the key players operating in the Latin America preclinical imaging systems market.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Modality                

                                5.1.1 Optical imaging      

                                                5.1.1.1 Bioluminescence/fluorescence imaging systems

                                                5.1.1.2 Standalone fluorescence imaging systems

                                                5.1.1.3 Optical + X-ray/optical + CT imaging systems

                                5.1.2 Nuclear imaging    

                                                5.1.2.1 Micro-PET systems (standalone PET, PET/CT, and PET/MRI)

                                                5.1.2.2 Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI)

                                                5.1.2.3 Tri-modality (PET/SPECT/CT) imaging systems

                                5.1.3 Micro-MRI               

                                5.1.4 Micro-CT  

                                5.1.5 Micro-ultrasound 

                                5.1.6 Photoacoustic        

                                5.1.7 Magnetic particle imaging systems               

                5.2 By Reagent                 

                                5.2.1 Optical imaging reagents   

                                                5.2.1.1 Bioluminescent reagents

                                                5.2.1.2 Fluorescent imaging reagents

                                5.2.2 Nuclear imaging reagents 

                                                5.2.2.1 Preclinical PET tracers

                                                5.2.2.2 Preclinical SPECT probes

                                5.2.3 MRI contrast agents            

                                5.2.4 Ultrasound contrast agents             

                                5.2.5 CT contrast agents               

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 Brazil             

                                6.3 Mexico         

                                6.4 Rest of Latin America             

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Aspect Imaging                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Biospace Lab S.A.                     

                8.3 Bruker Corporation                 

                8.4 LI-COR Biosciences                  

                8.5 Mediso Ltd.                

                8.6 MILabs B.V.                

                8.7 MR Solutions Ltd                      

                8.8 PerkinElmer               

                8.9 TriFoil Imaging                           

                8.10 FUJIFILM VisualSonics, Inc.                                

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Preclinical in-vivo imaging Market By Region, From 2018-2023 (USD Million)
  2. Latin America Preclinical in-vivo imaging Market By Modality, From 2018-2023 (USD Million)
  3. Latin America Preclinical Optical imaging Market By Region, From 2018-2023 (USD Million)
  4. Latin America Preclinical Bioluminescence/fluorescence imaging systems Market By Region, From 2018-2023 (USD Million)
  5. Latin America Preclinical Standalone fluorescence imaging systems Market By Region, From 2018-2023 (USD Million)
  6. Latin America Preclinical Optical + X-ray/optical + CT imaging systems Market By Region, From 2018-2023 (USD Million)
  7. Latin America Preclinical Nuclear imaging Market By Region, From 2018-2023 (USD Million)
  8. Latin America Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market By Region, From 2018-2023 (USD Million)
  9. Latin America Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market By Region, From 2018-2023 (USD Million)
  10. Latin America Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market By Region, From 2018-2023 (USD Million)
  11. Latin America Preclinical Micro-MRI Market By Region, From 2018-2023 (USD Million)
  12. Latin America Preclinical Micro-CT Market By Region, From 2018-2023 (USD Million)
  13. Latin America Preclinical Micro-ultrasound Market By Region, From 2018-2023 (USD Million)
  14. Latin America Preclinical Photoacoustic Market By Region, From 2018-2023 (USD Million)
  15. Latin America Preclinical Magnetic particle imaging systems Market By Region, From 2018-2023 (USD Million)
  16. Latin America Preclinical in-vivo imaging Market By Reagent, From 2018-2023 (USD Million)
  17. Latin America Preclinical Optical imaging reagents Market By Region, From 2018-2023 (USD Million)
  18. Latin America Preclinical Bioluminescent reagents Market By Region, From 2018-2023 (USD Million)
  19. Latin America Preclinical Fluorescent imaging reagents Market By Region, From 2018-2023 (USD Million)
  20. Latin America Preclinical Nuclear imaging reagents Market By Region, From 2018-2023 (USD Million)
  21. Latin America Preclinical PET tracers Market By Region, From 2018-2023 (USD Million)
  22. Latin America Preclinical SPECT probes Market By Region, From 2018-2023 (USD Million)
  23. Latin America Preclinical MRI contrast agents Market By Region, From 2018-2023 (USD Million)
  24. Latin America Preclinical Ultrasound contrast agents Market By Region, From 2018-2023 (USD Million)
  25. Latin America Preclinical CT contrast agents Market By Region, From 2018-2023 (USD Million)
  26. Brazil Preclinical in-vivo imaging Market By Modality, From 2018-2023 (USD Million)
  27. Brazil Preclinical Optical Imaging Market By Optical imaging, From 2018-2023 (USD Million)
  28. Brazil Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2018-2023 (USD Million)
  29. Brazil Preclinical in-vivo imaging Market By Reagent, From 2018-2023 (USD Million)
  30. Brazil Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2018-2023 (USD Million)
  31. Brazil Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2018-2023 (USD Million)
  32. Argentina Preclinical in-vivo imaging Market By Modality, From 2018-2023 (USD Million)
  33. Argentina Preclinical Optical Imaging Market By Optical imaging, From 2018-2023 (USD Million)
  34. Argentina Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2018-2023 (USD Million)
  35. Argentina Preclinical in-vivo imaging Market By Reagent, From 2018-2023 (USD Million)
  36. Argentina Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2018-2023 (USD Million)
  37. Argentina Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2018-2023 (USD Million)
  38. Mexico Preclinical in-vivo imaging Market By Modality, From 2018-2023 (USD Million)
  39. Mexico Preclinical Optical Imaging Market By Optical imaging, From 2018-2023 (USD Million)
  40. Mexico Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2018-2023 (USD Million)
  41. Mexico Preclinical in-vivo imaging Market By Reagent, From 2018-2023 (USD Million)
  42. Mexico Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2018-2023 (USD Million)
  43. Mexico Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2018-2023 (USD Million)

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients

Research Areas